Graybug and CalciMedica Enter into Definitive Merger Agreement
November 21, 2022 18:52 ET | Source: Graybug Vision, Inc.; CalciMedica Inc. Link here Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica’s pipeline of first-in-class product candidates for life-threatening inflammatory diseases Combined company is expected to be funded with cash and cash equivalents of approximately $35 million at closing, with an expected runway into […]